Exhibit 99.4
LOAN AGREEMENT
This LOAN AGREEMENT (the “Agreement”) is made and entered into as of January 15, 2025 (the “Effective Date”), by and between:
| 1. | Lenders: Lenders identified on the signature pages hereto (each, including its successors and assigns, each a “Lender” and collectively, the “Lenders”). | |
| 2. | Borrower: CHINA SXT PHARMACEUTICALS, INC., a company organized in the British Virgin Island (“Borrower”), with a principal business address at 178 Taidong Rd North, Taizhou, Jiangsu, China. |
The parties hereby agree as follows:
1. Loan Amount
Lenders agrees to lend to Borrower an aggregate principal sum of One Million Eight Hundred and Forty Thousand United States Dollars (USD 1,840,000) (the “Loan”).
2. Term
The term of this Loan shall be one (1) month from the date hereof (the “Maturity Date”). The date on which Lenders delivers the Loan proceeds to Borrower shall be referred to as the “Disbursement Date.”
3. Interest
| 1. | Borrower shall pay to Lenders interest on the unpaid principal balance of the Loan at the rate of one percent (1%) per annum. |
| 2. | Interest shall accrue from the Disbursement Date through the Maturity Date. |
4. Repayment
| 1. | Borrower shall repay the principal amount of USD 1,840,000, plus all accrued interest, in full on or before the Maturity Date. |
| 2. | Payment shall be made in United States Dollars via wire transfer to an account designated by Lenders (or in such other manner as the parties may agree in writing). |
5. Prepayment
Borrower may prepay the Loan, in whole or in part, at any time without penalty or premium. Any partial prepayment shall first be applied to accrued but unpaid interest, then to the outstanding principal.
6. Default
| 1. | An “Event of Default” shall occur if Borrower fails to pay the principal and accrued interest in full by the Maturity Date. |
| 2. | Upon an Event of Default, Lenders may declare all amounts due and payable immediately. |
| 3. | Borrower shall be responsible for all reasonable costs incurred by Lenders in enforcing its rights under this Agreement, including attorneys’ fees. |
7. No Security
This Loan is unsecured unless otherwise agreed in a separate writing executed by the parties.
8. Governing Law and Jurisdiction
This Agreement shall be governed by and construed in accordance with the laws of Hong Kong. Any dispute arising from this Agreement shall be brought and resolved in the courts located in Hong Kong, and the parties consent to personal jurisdiction in such courts.
9. Entire Agreement
This Agreement constitutes the entire understanding between the parties and supersedes all prior negotiations or understandings. This Agreement may be amended or modified only by a written instrument signed by both parties.
10. Counterparts
This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Signatures transmitted by email/PDF shall be effective as originals.
[Signature Pages Follow]
2
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first set forth above.
| BORROWER: | ||
| CHINA SXT PHARMACEUTICALS, INC. | ||
| By: | ||
| Name: | Feng Zhou | |
| Title: | CEO | |
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK
SIGNATURE PAGES FOR LENDERS FOLLOW]
3
